Related Experiment Video
Updated: May 18, 2026
06:03
Procedure for Adaptive Laboratory Evolution of Microorganisms Using a Chemostat
Published on: September 20, 2016
Toward a semisynthetic stress response system to engineer microbial solvent tolerance
Kyle A Zingaro1, Eleftherios Terry Papoutsakis
1Department of Chemical Engineering and Delaware Biotechnology Institute, University of Delaware, Newark, Delaware, USA.
Mbio
|October 4, 2012
Summary
Engineered Escherichia coli with heat shock proteins (HSPs) show enhanced tolerance to toxic solvents, improving biofuel and chemical production. This modular system offers a platform for customized microbial strain development.
Area of Science:
- Microbiology
- Biotechnology
- Metabolic Engineering
Background:
- Microbial production of chemicals is limited by product toxicity.
- Improving strain tolerance is crucial for developing efficient platform organisms.
- Heat shock proteins (HSPs) play a role in cellular stress response.
Purpose of the Study:
- To engineer a semisynthetic stress response system in Escherichia coli for enhanced solvent tolerance.
- To investigate the efficacy of co-overexpressing specific HSPs for improved tolerance to toxic solvents.
- To establish a tunable system for engineering customized microbial tolerance phenotypes.
Main Methods:
- Co-overexpression of selected heat shock proteins (HSPs) including GrpE, GroESL, and ClpB in Escherichia coli.
- Utilizing different plasmid combinations and inducible promoters to tune HSP gene expression levels.
- Assessing strain tolerance by measuring viable cell counts (CFU) after exposure to various solvents (ethanol, n-butanol, 1,2,4-butanetriol).
Main Results:
- Simultaneous overexpression of GrpE and GroESL increased viable cells by 2-fold in 5% ethanol.
- Co-overexpression of GroESL and ClpB resulted in significant CFU increases in ethanol and butanol isomers.
- Co-overexpression of GrpE, GroESL, and ClpB demonstrated substantial tolerance improvements to ethanol, n-butanol, and 1,2,4-butanetriol.
Conclusions:
- Tuned co-overexpression of specific HSPs (GroES, GroEL, ClpB, GrpE) significantly enhances E. coli tolerance to toxic solvents.
- The developed semisynthetic stress response system provides a modular platform for engineering customized tolerance.
- This approach facilitates the development of more robust microbial strains for biotechnological applications.
Related Concept Videos
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:30Other Stress Responses in Bacteria
Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...